As of 2026-10-01, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (32.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -73554.9%.
The range of the Relative Valuation is (27.02) - (35.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 28.5x | 26.0x |
| Forward P/E multiples | 20.2x - 28.9x | 26.1x |
| Fair Price | (27.02) - (35.87) | (32.83) |
| Upside | -60555.8% - -80350.5% | -73554.9% |
| Date | P/E |